http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111743912-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-17 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 |
| filingDate | 2020-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111743912-B |
| titleOfInvention | Gene inhibitor for promoting colon cancer cell apoptosis and inhibiting colon cancer cell migration |
| abstract | The invention provides a gene inhibitor for preparing a medicine for promoting colon cancer cell apoptosis and inhibiting colon cancer cell migration, and belongs to the technical field of biomedicine. Experiments prove that the LINC02360 gene inhibitor can promote the apoptosis of colon cancer cells and can inhibit the migration and invasion of the colon cancer cells by regulating the protein expression of E-cadherin and N-cadherin. Therefore, the siRNA of LINC02360 can be used for preparing a medicine for promoting the apoptosis of colon cancer cells and can be used for preparing a medicine for inhibiting the migration and invasion of the colon cancer cells. |
| priorityDate | 2020-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 203.